Turkey’s Drug Bill Dips In 2012; Industry Blames Unsustainable Pressure, Government Cites Efficiencies
This article was originally published in PharmAsia News
Executive Summary
Turkey’s spending on drug reimbursement dropped last year as pressure was brought by government price cuts, but manufacturers say the trend is unsustainable. The government says some of the $747 million it saved was because of heightened use of electronic tracking for prescriptions.